Related Experiment Video
Updated: Oct 1, 2025
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.5K
Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases
Thierry Soussi1,2, Panagiotis Baliakas1
1Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Frontiers in Oncology
|March 7, 2022
Summary
TP53 mutation databases are crucial for chronic lymphocytic leukemia (CLL) research. Analyzing TP53 profiles reveals significant subclonal mutations and heterogeneity, aiding clinical diagnosis and prognosis.
Area of Science:
- Genomics
- Oncology
- Bioinformatics
Background:
- Locus-specific databases compile expert-curated information from literature.
- Cancer genome databases store vast amounts of data from sequencing projects.
- TP53 defects are independent prognostic factors in chronic lymphocytic leukemia (CLL).
Purpose of the Study:
- To review the heterogeneity of TP53 variants in CLL.
- To highlight the utility of TP53 mutation databases in clinical practice.
- To analyze TP53 profiles within CLL using mutation databases.
Main Methods:
- Analysis of TP53 mutation databases.
- Review of literature on TP53 variants in CLL.
- Examination of TP53 profiles in tumor samples.
Main Results:
- CLL TP53 profiles exhibit extensive subclonal mutations with low variant allelic frequencies.
- Multiple minor subclones with distinct TP53 mutations are frequently observed.
- TP53 mutation databases are essential for validating numerous detected variants.
Conclusions:
- TP53 mutation databases are vital for understanding CLL heterogeneity.
- Analysis of TP53 variants aids in the clinical diagnosis and prognosis of CLL.
- Understanding TP53 heterogeneity is key to improving patient outcomes in CLL.
